Because tumor cells, including gliomas, can aberrantly express lineage nonspecific molecules (64), we evaluated CD69 expression on the GL261 glioma cell line (Supplementary Fig. S1D) and dissociated GL261 tumor tissue post ICI treatment by flow cytometry (Supplementary Fig. S1E). This evidence concerns the gene CD69 and central nervous system cancer.